MedTrace Logo

Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19

NCT04598581 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2021-04-19

No results posted yet for this study

Summary

This study is to analyse the efficacy of LD-RT for treatment of Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2).

Conditions

  • Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2)

Interventions

RADIATION

Low Dose Radiation Therapy (LD-RT)

Low Dose Radiation Therapy (LD-RT) of both lungs with 1 Gray

OTHER

Sham irradiation

Sham irradiation

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Alexandros Papachristofilou, Dr. med. · Department of Radiooncology, University Hospital Basel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-02
Primary Completion
2021-04-09
Completion
2021-04-09

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04598581 on ClinicalTrials.gov